The discovery of LML134, a histamine H3 receptor inverse agonist for the clinical treatment of excessive sleep disorders.

The discovery of LML134, a histamine H3 receptor inverse agonist for the clinical treatment of excessive sleep disorders. ChemMedChem. 2019 Apr 08;: Authors: Troxler T, Feuerbach D, Zhang X, Yang C, Lagu B, Perrone M, Wang TL, Briner K, Bock M, Auberson YP PMID: 30957954 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30957954?dopt=Abstract

Source: ChemMedChem - April 7, 2019 Category: Chemistry Authors: Troxler T, Feuerbach D, Zhang X, Yang C, Lagu B, Perrone M, Wang TL, Briner K, Bock M, Auberson YP Tags: ChemMedChem Source Type: research

More News: Chemistry | Sleep Disorders | Sleep Medicine